Results 111 to 120 of about 5,164,002 (344)

High toughness-high strength iron alloy [PDF]

open access: yes, 1980
An iron alloy is provided which exhibits strength and toughness characteristics at cryogenic temperatures. The alloy consists essentially of about 10 to 16 percent by weight nickel, about 0.1 to 1.0 percent by weight aluminum, and 0 to about 3 percent by
Stephens, J. R., Witzke, W. R.
core   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

open access: yesMolecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix   +13 more
wiley   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

Boost to SNAP Benefits Protected Young Children's Health [PDF]

open access: yes, 2011
The Great Recession has taken a significant toll on America's children.
Ashley Schiffmiller   +6 more
core  

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

We Are in This Together: A Survey of Community Arts Partners in LA County Public Schools [PDF]

open access: yes, 2015
The Los Angeles County Arts Commission surveyed teaching artists and arts organizations to find out who provided arts education services to LA County's 2,198 public schools in 2012.
Bronwyn Mauldin
core  

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

The Ninety-Nine Percent and the One Percent

open access: yesResearch in Applied Economics, 2014
This paper explores income inequality from different angles. It tries to understand the possible reasons for income inequality that exist in the modern world. It supports the notion that exceptionally talented individuals using technology has been a reason behind rising income inequality.
openaire   +3 more sources

U. S. Trade in Tuna for Canning, 1987 [PDF]

open access: yes, 1990
U.S. tuna fleet activity, canned tuna processing, ex-vessel, wholesale and retail prices and imports in 1987 are described and compared to their counterparts in previous years.
Donley, Patricia J.   +2 more
core  

Crucial parameters for precise copy number variation detection in formalin‐fixed paraffin‐embedded solid cancer samples

open access: yesMolecular Oncology, EarlyView.
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy